CCM
GH icon

CAAS Capital Management’s Guardant Health GH Stock Holding History

CAAS Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-63,095
Closed -$7.84M – 1016
2021
Q2 		$7.84M Buy
+63,095
New +$8.49M 0.13% 178
2020
Q3 		– Sell
-117,242
Closed -$9.51M – 532
2020
Q2 		$9.51M Buy
+117,242
New +$9.45M 0.31% 78

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

CAAS Capital Management's GH Position: Q3 2021 in Review

CAAS Capital Management sold out of Guardant Health (GH) in Q3 2021, closing a stake of 63,095 shares — an estimated $7.84M sold.

CAAS Capital Management first reported a position in GH in Q2 2020 and held it in 2 quarters. The position peaked at $9.51M in Q2 2020. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

  • CAAS Capital Management reported no remaining Guardant Health position as of Q3 2021 after selling out during the quarter.
  • CAAS Capital Management sold 63,095 Guardant Health shares in Q3 2021, an estimated $7.84M.
  • CAAS Capital Management first reported a position in Guardant Health in Q2 2020 and held it in 2 quarters.
  • CAAS Capital Management's Guardant Health position peaked at $9.51M in Q2 2020.
  • 374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on CAAS Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.